Alchemab Therapeutics

Alchemab TherapeuticsAlchemab Therapeutics
Alchemab Therapeutics

Alchemab Therapeutics

Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals.

Website
2019ActiveLondon, United Kingdom
Rate
Advertise here

About

Alchemab Therapeutics is a clinical-stage biotechnology startup founded in 2019. The company focuses on discovering and developing novel antibody therapeutics by identifying naturally occurring protective antibodies from individuals who are resilient to specific diseases. They utilize well-defined patient samples, deep B cell sequencing, and computational analysis to identify convergent protective antibody responses. These identified antibodies are then developed into therapeutic products for hard-to-treat diseases.

Technology stack

detected 2026-07-14
Email
Hosting
Stack
Analytics
Video
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Alchemab Therapeutics do?

Alchemab Therapeutics is a clinical-stage biotechnology startup founded in 2019. The company focuses on discovering and developing novel antibody therapeutics by identifying naturally occurring protective antibodies from individuals who are resilient to specific diseases. They utilize well-defined patient samples, deep B cell sequencing, and computational analysis to identify convergent protective antibody responses. These identified antibodies are then developed into therapeutic products for ha…

How much funding has Alchemab Therapeutics raised?

Alchemab Therapeutics has raised a total of $32M in funding. The most recent round on record is Series A.

Where is Alchemab Therapeutics headquartered?

Alchemab Therapeutics is headquartered in London, England, United Kingdom.

When was Alchemab Therapeutics founded?

Alchemab Therapeutics was founded in 2019.

What industry does Alchemab Therapeutics operate in?

Alchemab Therapeutics operates in Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery, Biotech, Clinical Trials.

What is Alchemab Therapeutics's revenue?

StartupHub estimates Alchemab Therapeutics's annual revenue at $3.7M (range $1.0M to $12.0M, 37% confidence), based on comparable companies in the sector.

What is Alchemab Therapeutics's valuation?

StartupHub estimates Alchemab Therapeutics's effective valuation at $120.3M (range $78.8M to $189.0M, 25% confidence), based on comparable companies in the sector.